Atrial flutter
Atrial flutter (AF) refers to rapid and regular atrial electrical activity. On the electrocardiogram, it appears as atrial flutter waves of equal size, fast and regular frequency (atrial rate is generally 240 to 340 times/min), and no isoelectric lines.
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
Patients with organic heart disease often -
Related symptoms:
Palpitations dizziness difficulty breathing holiday heart syndrome palpitations
Related Drugs
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
Wuhan Wujing Pharmaceutical Co., Ltd.
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
Hainan Pharmaceutical Factory Co., Ltd. Pharmaceutical Factory No.1
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
Shandong XinYi Pharmaceutical Co., Ltd.
Quinidine sulfate tablets
Indication: It is mainly used for the maintenance treatment of atrial fibrillation or atrial flutter after electrical cardioversion. Although it is effective for atrial premature beats, paroxysmal supraventricular tachycardia, preexcitation syndrome with supraventricular arrhythmia, ventricular premature beats, ventricular tachycardia, and has the effect of cardioverting atrial fibrillation or atrial flutter, it is rarely used now due to many adverse reactions. Intramuscular and intravenous injections are no longer used.
Quinidine sulfate tablets
Indication: It is mainly used for the maintenance treatment of atrial fibrillation or atrial flutter after electrical cardioversion. Although it is effective for atrial premature beats, paroxysmal supraventricular tachycardia, preexcitation syndrome with supraventricular arrhythmia, ventricular premature beats, ventricular tachycardia, and has the effect of converting atrial fibrillation or atrial flutter, it is rarely used now due to many adverse reactions.
Quinidine sulfate tablets
Indication: Oral administration is mainly suitable for the maintenance treatment of atrial fibrillation or atrial flutter after electrical cardioversion. Although it is effective for atrial premature beats, paroxysmal supraventricular tachycardia, preexcitation syndrome with supraventricular arrhythmia, ventricular premature beats, ventricular tachycardia, and has the effect of cardioverting atrial fibrillation or atrial flutter, it is rarely used now due to many adverse reactions. Intramuscular and intravenous injections are no longer used.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Esmolol Hydrochloride Injection
Indication: Used to control ventricular rate in atrial fibrillation, atrial flutter, perioperative hypertension, sinus tachycardia
Manufacturer:
Huarun Shuanghe Limin Pharmaceutical (Ji'nan) Co., Ltd.
Esmolol Hydrochloride Injection
Indication: Used to control ventricular rate in atrial fibrillation, atrial flutter, perioperative hypertension, sinus tachycardia
Digoxin tablets
Indication: 1. Used for acute and chronic heart failure such as hypertension, valvular heart disease, congenital heart disease, etc. It is especially suitable for heart failure with atrial fibrillation accompanied by rapid ventricular rate; it has poor efficacy for heart failure caused by cor pulmonale, severe myocardial ischemia, active myocarditis and extracardiac factors such as severe anemia, hypothyroidism and vitamin B1 deficiency; 2. Used to control the ventricular rate and supraventricular tachycardia of patients with atrial fibrillation and atrial flutter accompanied by rapid ventricular rate.
Manufacturer:
Shanghai Yurui BIOTECHNOLOGY (Anyang) Pharmaceutical Co., Ltd.
Related Ingredients